Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

The requested reference [e309adb24a666bf68b21ef498fd949ef65fee159] no longer exists in our database. It has been replaced by the current reference: [28fbdc530347fcd34b628651d6327d3fe3c5278d]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to evaluate the efficacy and safety of lower dose calcineurin inhibitors (CNI) in combination with Everolimus in Korean heart transplant recipients.
Epistemonikos ID: 1ecb5a0d3d314d247b5666f8f226a62412d91eec
First added on: Apr 25, 2025